Researchers aligned with the Nevada State Athletic Commission have found that use of a portable CT scanner can effectively screen professional boxers for intracranial hemorrhage following matches.
Researchers aligned with the Nevada State Athletic Commission have found that use of a portable CT scanner can effectively screen professional boxers for intracranial hemorrhage following matches.
Acute subdural hematoma is the most common injury in boxing and the leading cause of boxing fatalities. Early diagnosis of these intracranial injuries in boxers is associated with better outcomes, said Dr. Albert H. Capanna, a Nevada ringside physician and clinical professor of neurosurgery and pediatrics at the University of Nevada School of Medicine.
While the researchers found no clinical signs or symptoms of injury in any athletes, CT demonstrated in one boxer, who lost by a technical knockout, a 6.2-mm acute subdural hematoma with positive evidence of midline shift of 4.2 mm. Surgical evacuation is indicated in the management of acute subdural hematomas greater than 10 mm in thickness or associated with a midline shift of 5 mm.
The patient was promptly admitted to a nearby hospital, and the subdural hematoma improved over the subsequent two days, including complete resolution of the previous midline shift by discharge on the third day.
The Nevada state legislature has provided funding to the State Athletic Commission to have CT imaging available at athletic venues for immediate use in screening athletes with head injury. However, further studies are needed to risk stratify athletes before including them in long-term screening protocols because of the cumulative radiation dose associated with this practice, Capanna said.
Large Study Affirms Safety of Ultrasound Enhancing Agents for Echocardiography
May 16th 2025Those receiving ultrasound enhancing agents (UEAs) for transthoracic or stress echocardiography had lower odds of all-cause death in comparison to patients who did not have UEAs, according to a nationwide study involving 11.4 million patients.
BrightHeart Garners Third FDA Clearance for AI-Powered Assessments of Fetal Heart Ultrasound
May 14th 2025The latest FDA 510(k) clearance is for B-Right Views, an AI-enabled device, which provides automated detection of required views necessary for second- and third-trimester fetal heart ultrasound exams.